WO/2016/169413 ECHO CANCELLATION DATA SYNCHRONIZATION CONTROL METHOD, TERMINAL, AND STORAGE MEDIUM||WO||27.10.2016|
||PCT/CN2016/078661||TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED||ZHOU, Xiaoxing|
An echo cancellation data synchronization control method. The method comprises: estimating a sound card delay value; waiting for a result that a difference obtained by subtracting a near-end audio buffer queue length from a reference audio buffer queue length is greater than or equal to an audio data length corresponding to the sound card delay value; taking out audio data from a queue head of the reference audio buffer queue and a queue head of the near-end audio buffer queue according to audio frames so as to perform echo cancellation; obtaining a relative delay value generated by echo cancellation processing; and adjusting the sound card delay value according to the relative delay value.
WO/2016/169414 MULTIUSER INFORMATION PROCESSING METHOD AND APPARATUS||WO||27.10.2016|
||PCT/CN2016/078850||ZTE CORPORATION||YUAN, Zhifeng|
A multiuser information processing method and apparatus. The method comprises: dividing user information into i groups, wherein each group comprises user information of n users, i is a positive integer, n is a positive integer greater than or equal to 2; and separately performing mixed processing on the user information of the n users in the i groups, so as to obtain i mixed symbols; and extending the i mixed symbols by using i K-length sequences, so as to obtain i K-length symbol sequences, wherein K is a positive integer. The apparatus comprises a mixing module and an extending module. By using the method and the apparatus in embodiments of the present invention, a system obtains diversity gain, a terminal obtains better SIC robustness; in addition, the terminal can be scheduled in a full bandwidth simply and conveniently.
WO/2016/169415 LIGHTING CONTROL METHOD, LIGHTING APPARATUS, AND SYSTEM||WO||27.10.2016|
||PCT/CN2016/078865||ZHEJIANG SHENGHUI LIGHTING CO., LTD.||XU, Yi|
A lighting control method, a related lighting apparatus and system are provided. The lighting control method includes detecting a connection status of a wireless network component of a lighting apparatus(S101) and controlling a working status of an illumination component of the lighting apparatus based on the connection status (S102).
WO/2016/169416 METHODS OF TISSUE REPAIR AND REGENERATION||WO||27.10.2016|
||PCT/CN2016/078873||INNOLIFE CO., LTD.||KANG, Yujian James|
The disclosure provides local delivery of a trace element to a site of tissue injury, which triggers the body' inherent tissue repair mechanism. Local delivery of copper to the site of injury induces migration (i.e., homing) of stem cells to the site of injury, triggers differentiation of stem cells at the site of injury, induces tissue regeneration at the site of injury, induces signaling molecules that trigger tissue regeneration, reverses damage at the site of injury, and/or reconstructs the microenvironment of neurofibril cells and neurosecretory cells at the site of injury. In another aspect, delivering a trace element (for example, copper) directly to the site of injury and associated methods are disclosed.
WO/2016/169417 PURINYL-N-HYDROXYL PYRIMIDINE FORMAMIDE DERIVATIVES, PREPARATION METHOD THEREFOR AND USE THEREOF||WO||27.10.2016|
||PCT/CN2016/079022||CHENGDU JINRUI EVERGREEN BIOTECH CO.,LTD.||CHEN, Lijuan|
The present invention relates to the field of the chemical medicines, and in particular, to purinyl-N-hydroxyl pyrimidine formamide derivatives, a preparation method therefor and a use thereof. The present invention provides a purinyl-N-hydroxyl pyrimidine formamide derivative having a structure represented by formula (I). The invention also provides a method for preparing said purinyl-N-hydroxyl pyrimidine formamide derivative and a use thereof. Purinyl-N-hydroxyl pyrimidine formamide derivative provided in the invention can be not only a PI3K and HDAC double-functional target kinase inhibitor, but also a PI3K or HDAC single target kinase inhibitor, thus providing new choice for preparing multi-target inhibitors.
WO/2016/169418 DATA TRANSMISSION METHOD AND DEVICE||WO||27.10.2016|
||PCT/CN2016/079026||ALIBABA GROUP HOLDING LIMITED||LI, Qingfeng|
Disclosed in the present application are a data transmission method and device corresponding thereto. The data transmission method comprises the following steps: determining a receiving party; determining a data transmission specification; transmitting data to the receiving party according to the determined data transmission specification, wherein the data transmission specification relates to at least one of a remaining time to expiration of the data transmission, a ratio of a remaining data volume to the total data volume and a ratio of the remaining data volume to the remaining capacity of the receiving party. Thereby, the present invention can adjust the data transmission in a timely manner according to a state of the data transmission, thus providing a good user experience and high execution efficiency.
WO/2016/169419 MOBILE TERMINAL UNLOCKING METHOD AND DEVICE||WO||27.10.2016|
||PCT/CN2016/079027||ALIBABA GROUP HOLDING LIMITED||LI, Kai|
A mobile terminal unlocking method and device. The method comprises: establishing, by a wearable Bluetooth device, a connection with a mobile terminal, determining a corresponding current state of the mobile terminal; the current state is a locked state or an unlocked state (101); detecting, by the wearable Bluetooth device, an authorization behavior of the user, and using the authorization behavior of the user to set a corresponding processing identifier of the mobile terminal; the processing identifier is a locking identifier or an unlocking identifier (102); when the processing identifier is the unlocking identifier, and the current state is the locked state, transmitting, by the wearable Bluetooth device, an unlocking message to the mobile terminal, and performing, by the mobile terminal, an unlocking operation (103). In this method, the wearable Bluetooth device can perform the unlocking operation or the locking operation on the mobile terminal on the basis of the will of an owner of the mobile terminal, i.e., a real intention of the user, improving user experience and effectively protecting user privacy.
WO/2016/169420 METHOD, DEVICE AND SYSTEM FOR QUERYING SERVICE REQUEST EXECUTION STATE||WO||27.10.2016|
||PCT/CN2016/079050||ALIBABA GROUP HOLDING LIMITED||HUANG, Mengjun|
Disclosed is a method for querying a service request execution state, the method satisfying different time limit requirements for obtaining an execution state of different services having an unclear state. The method comprises: obtaining an identifier code and service characteristic of the service having an unclear state; and querying, according to the service characteristic and by utilizing the identifier code, the execution state of the service having an unclear state. Also disclosed in the present application are a device and system for querying the service request execution state.
WO/2016/169421 IMIDAZO ISOINDOLE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF||WO||27.10.2016|
||PCT/CN2016/079054||JIANGSU HENGRUI MEDICINE CO., LTD.||TU, Wangyang|
The present invention relates to an imidazo isoindole derivative, a preparation method therefor and a medical use thereof. In particular, the present invention relates to the imidazo isoindole derivative as shown in the formula (I), a preparation method and pharmaceutical composition containing the derivative, and a use thereof for treating diseases with the pathological characteristic of IDO-mediated tryptophan metabolic pathways. The diseases comprise cancers, Alzheimer's disease, autoimmune diseases, depression, anxiety disorders, cataracts, psychological disorders and AIDS, wherein the substituents in the formula (I) are the same as those defined in the description.
WO/2016/169422 CRYSTAL FORM OF A CYCLIN-DEPENDENT KINASE INHIBITOR AND THE PREPARATION METHOD THEREOF||WO||27.10.2016|
||PCT/CN2016/079055||JIANGSU HENGRUI MEDICINE CO., LTD.||WU, Guaili|
Provided are the crystal form of a cyclin-dependent kinase inhibitor (CDK&6) and a preparation method thereof. In particular, provided are II-type crystals of 6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperidin-4-yl)pyridin-2-yl) amino)pyridino[2,3-d]pyrimidin-7(8H)-one (compound of formula (I)) and the preparation method thereof, the crystal having an X-ray powder diffraction pattern as shown in figure 1, a good chemical stability and crystal form stability, and using a low toxicity, low residual crystallization solvent, so as to be better used for clinical treatment.